SV40 T/t Interactions with Pocket Proteins
SV40 T/t Interactions with Pocket Proteins
批准号:
6989679
负责人:
DAVID Morse LIVINGSTON
金额:
$28.1万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-04-27 至 2009-02-28
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We have accumulated evidence pointing to a distinctive role of the un(der)phosphorylated form of the Rb protein during S phase that is blocked by SV40 small t Ag. Specifically, Rb can suppress the rereplication of DNA segments after DNA damage, at least in part by homing to and forming complexes with multiple genomic replication initiation elements. In preparation for post-damage replication site localization, Rb must also localize in the chromatin fraction, a process that we have shown is pp2A-dependent. Thus, small t blocks Rb/chromatin localization and, thereby, its ability to home to replication initiation sites after DNA damage. One end product of small t action in this regard was endoreduplicafion of cellular DNA. In addition, we have found that the product of the Nijmegen Break Syndrome gene, Nbs1, is a heretofore unappreciated large TAg binding protein; that Nbs1, like Rb, participates in rereplication suppression-both of cellular replicons and the viral genome; and that TAg can, upon Nbs1 binding, override this activity. The latter effect may well contribute to the established ability of T in inducing genomic rereplication as well as fully autonomous replication of circular DNA structures that contain an SV40 replication origin. In this application, we propose to search for: 1) biochemical evidence that sheds light on how Rb and Nbs1 suppress genomic rereplication; 2) for insights into where during the cell cycle the pp2A Rb/chromatin entry process is applicable; 3) for information on how pp2A operates biochemically in this process, and 4) for evidence indicating whether or not Rb and/or other pocket proteins serve as key small t targets during the performance of its neoplastic co-transforming function in human cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Deciphering the mechanism underlying BRCA1 breast cancer development
-
批准号:10218120
-
项目类别:
-
资助金额:$105.34万
-
财政年份:2019
-
负责人:DAVID Morse LIVINGSTON
-
依托单位:
Deciphering the mechanism underlying BRCA1 breast cancer development
-
批准号:9814452
-
项目类别:
-
资助金额:$84.51万
-
财政年份:2019
-
负责人:DAVID Morse LIVINGSTON
-
依托单位:
BRCA1 Function in Post-Damage Nuclear Foci
-
批准号:9454879
-
项目类别:
-
资助金额:$3.38万
-
财政年份:2017
-
负责人:DAVID Morse LIVINGSTON
-
依托单位:
Viral Oncoprotein Inhibition of Quiescence
-
批准号:8233033
-
项目类别:
-
资助金额:$44.63万
-
财政年份:2011
-
负责人:DAVID Morse LIVINGSTON
-
依托单位:
Administrative Core
-
批准号:8233035
-
项目类别:
-
资助金额:$4.04万
-
财政年份:2011
-
负责人:DAVID Morse LIVINGSTON
-
依托单位:
BRCA 1 and 2 and Breast Cancer Development
-
批准号:8215974
-
项目类别:
-
资助金额:$46.74万
-
财政年份:2011
-
负责人:DAVID Morse LIVINGSTON
-
依托单位:
Viral Oncoprotein Inhibition of Quiescence
-
批准号:7647592
-
项目类别:
-
资助金额:$45.18万
-
财政年份:2009
-
负责人:DAVID Morse LIVINGSTON
-
依托单位:
BRCA1 Function in Post-Damage Nuclear Foci
-
批准号:9196343
-
项目类别:
-
资助金额:$51.55万
-
财政年份:2009
-
负责人:DAVID Morse LIVINGSTON
-
依托单位:
BRCA1 Function in Post-Damage Nuclear Foci
-
批准号:8465745
-
项目类别:
-
资助金额:$48.08万
-
财政年份:2009
-
负责人:DAVID Morse LIVINGSTON
-
依托单位:
BRCA1 Function in Post-Damage Nuclear Foci
-
批准号:8080170
-
项目类别:
-
资助金额:$51.17万
-
财政年份:2009
-
负责人:DAVID Morse LIVINGSTON
-
依托单位:
Administrative Core
-
批准号:7647595
-
项目类别:
-
资助金额:$4.09万
-
财政年份:2009
-
负责人:DAVID Morse LIVINGSTON
-
依托单位:
BRCA1 Function in Post-Damage Nuclear Foci
-
批准号:9027449
-
项目类别:
-
资助金额:$51.55万
-
财政年份:2009
-
负责人:DAVID Morse LIVINGSTON
-
依托单位:
Biology and treatment of Brca1-Associated and Sporadic Basal-Like cancers
-
批准号:7927063
-
项目类别:
-
资助金额:$13.26万
-
财政年份:2009
-
负责人:DAVID Morse LIVINGSTON
-
依托单位:
BRCA1 Function in Post-Damage Nuclear Foci
-
批准号:8266522
-
项目类别:
-
资助金额:$51.16万
-
财政年份:2009
-
负责人:DAVID Morse LIVINGSTON
-
依托单位:
BRCA1 Function in Post-Damage Nuclear Foci
-
批准号:7729519
-
项目类别:
-
资助金额:$44.38万
-
财政年份:2009
-
负责人:DAVID Morse LIVINGSTON
-
依托单位:
BRCA 1 and 2 and Breast Cancer Development
-
批准号:7617418
-
项目类别:
-
资助金额:$48.71万
-
财政年份:2009
-
负责人:DAVID Morse LIVINGSTON
-
依托单位:
Biology and treatment of Brca1-Associated and Sporadic Basal-Like cancers
-
批准号:7729483
-
项目类别:
-
资助金额:$7.76万
-
财政年份:2008
-
负责人:DAVID Morse LIVINGSTON
-
依托单位:
BRCA1 and the Inactive X Chromosome
-
批准号:6696977
-
项目类别:
-
资助金额:$34.45万
-
财政年份:2004
-
负责人:DAVID Morse LIVINGSTON
-
依托单位:
BRCA1 and the Inactive X Chromosome
-
批准号:6892151
-
项目类别:
-
资助金额:$33.14万
-
财政年份:2004
-
负责人:DAVID Morse LIVINGSTON
-
依托单位:
BRCA1 and the Inactive X Chromosome
-
批准号:7192487
-
项目类别:
-
资助金额:$32.89万
-
财政年份:2004
-
负责人:DAVID Morse LIVINGSTON
-
依托单位:
海外基金